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A B S T R A C T
We report a case of nosocomial mediastinitis and sternal osteitis due to M. hominis after open-heart
surgery in an immuno-competent patient. This infection has been diagnosed by incubating the culture
media for an extended period of time, and sequencing 16S rDNA directly from the clinical samples.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Post-operative mediastinitis is a classic complication of open-
heart surgery, occurring with an incidence of 1.3%.1 Coagulase-
negative staphylococci or Staphylococcus aureus are isolated from
the majority of the patients (46% and 26%, respectively).1
Mycoplasma spp. are exceptionally involved in post-operative
mediastinitis. We report a case of nosocomial mediastinitis and
sternal osteitis due to M. hominis after open-heart surgery in an
immuno-competent patient.
2. Case Report
A 37 year-old man consulted for thoracic pain. His cardiovas-
cular disease risk factors were uncontrolled hypertension and
tobacco smoking. The electrocardiogram was normal, but the
troponin was elevated (57 ng/mL). A grade II aortic regurgitation
was diagnosed by echocardiography, associated with a 5 mm
pericarditis. A chest CT scan conﬁrmed a type A aortic dissection,
according to the Stanford classiﬁcation. The patient underwent
emergency surgical replacement of the ascending aorta. On day* Corresponding author. Institute of Microbiology, University Hospital Center,
Lille, France. Tel.: +33 3 20 44 54 80.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).4 post-surgery, the patient suffered from aortic rupture with
hemothorax. The aortic arch was replaced by an aortic prosthesis
during open-heart surgery. Then, a thoracic endoprosthesis was
deployed 24 hours later through endovascular means.
The patient developed a ventilator-associated pneumonia due
to Escherichia coli on day 14 and was treated by ceftriaxone for one
week. A purulent discharge from the sternotomia associated with
fever (39.6 8C) was noticed on day 20. Nosocomial mediastinitis
was suspected. Ceftriaxone was switched to piperacillin-tazobac-
tam, daptomycin and caspofungin to cover a large spectrum of
bacteria and fungi. However, the antimicrobial therapy did not
seem effective. On day 23, an aggressive surgical drainage with
debridement of the infected tissues was performed. Sternal bone
and pre-sternal abscess biopsies were sent to the bacteriology
laboratory. Direct examination showed no bacteria on the Gram-
stain, but there were a high number of leukocytes. After 4 days of
culture, pin-point colonies were visible on blood agar from the
bone biopsy and abscess samples. No reliable identiﬁcation could
be obtained using MALDI-TOF mass spectrometry (Bruker Dal-
tonics, Wissembourg, France). A Gram-stain performed on the
colonies showed no bacteria. 16S rDNA was sequenced directly
from the clinical samples and also from the bacterial colonies.
Mycoplasma hominis was identiﬁed with 99% identity. To conﬁrm
this unusual result, we used M. hominis speciﬁc primers on the
clinical samples,2 and M. hominis DNA was also ampliﬁed. Our
isolate was classiﬁed as susceptible to oﬂoxacin and tetracyclin,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Clinical characteristics of the reported cases of post-operative mediastinitis due to M. hominis.
Patient number Age Sex Onset of disease (days) Fever Purulent discharge Survival Reference
1 62 Male 17 No Yes Yes Sielaff
2 63 Male 90 No Yes Yes Sielaff
3 48 Male 30 Yes Yes Yes Sielaff
4 78 Male 4 Yes Yes Yes Mattila
5 68 Male 12 Yes Yes No Mattila
6 44 Male 6 Yes Yes Yes Mattila
7 51 Male 2 Yes Yes Yes Mattila
8 58 Male 9 Yes Yes Yes Mattila
9 51 Male 1 Yes No Yes Mattila
10 55 Male 8 Yes Yes Yes Hopkins
11 52 Male 16 No Yes Yes Hopkins
12 21 Male 14 No Yes Yes Hopkins
13 17 Male 21 No No Yes Hopkins
14 77 Male 4 Yes No No Garcia
15 55 Male 22 Yes Yes Yes Myers
16 56 Male 26 Yes Yes Yes Karaca
17 37 Male 20 Yes Yes Yes Le Guern
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was switched to levoﬂoxacin on day 27. The fever quickly subsided,
and the purulent discharge from the sternotomia stopped. Finally,
the patient made a complete recovery after 6 months of
antimicrobial therapy with levoﬂoxacin.
3. Discussion
This is the ﬁrst case of sternal osteitis due to M. hominis reported
in the literature. There is a lack of prospective studies evaluating
the prevalence of M. hominis and Ureaplasma spp. in mediastinitis.
Only 17 cases of post-operative mediastinitis due to M. hominis
have been published during the last 20 years.3–8 The median onset
of clinical symptoms was 14 days after surgery, with a minimum of
1 day and a maximum of 90 days (Table 1). The most frequent
symptoms were the presence of a purulent discharge (14/17, 82%)
and hyperthermia (12/17, 71%). The median age was 55 years old,
and 88% (15/17) of the patients survived after appropriate
antimicrobial treatment.
Interestingly, all the patients infected with M. hominis were
males (17/17, 100%). This can be partly explained because the
patients undergoing cardiac surgery are predominantly males
(72%).9 Although the prevalence of M. hominis is higher in the
genitourinary tract of women (393/2689, 14.6%) than males
(78/2336, 3.3%),10 it could be hypothesized that post-operative
M. hominis mediastinitis is linked with urinary catheterization.
Indeed, urinary catheterization is more traumatic in males, and itTable 2
Microbiological data of the reported cases of post-operative mediastinitis due to M. ho
Patient number Growth Medium Culture atm
1 Brucella Anaerobic 
2 Brucella Anaerobic 
3 Brucella Anaerobic 
4 Fastidious Anaerobe Anaerobic 
5 Fastidious Anaerobe Anaerobic 
6 Fastidious Anaerobe Anaerobic 
7 Fastidious Anaerobe Anaerobic 
8 Fastidious Anaerobe Anaerobic 
9 Fastidious Anaerobe Anaerobic 
10 Chocolate CO2 
11 Chocolate CO2 
12 Chocolate CO2 
13 Chocolate CO2 
14 Blood, Chocolate Air, CO2, An
15 Not speciﬁed Not speciﬁe
16 Not speciﬁed Not speciﬁe
17 Blood, Chocolate Air, CO2 may lead to bloodstream invasion.3 M. hominis can also colonize
the upper respiratory tract, but this is less frequent (3%).5
The diagnosis of extra-genital Mycoplasma infections is difﬁcult
because these bacteria do not possess a cell wall. Thus, they are not
visible using a Gram-stain. Mycoplasma have fastidious growth
requirements: a medium supplemented with nucleic acid pre-
cursors is needed, and the addition of serum enhance their
growth.11 However, M. hominis is less fastidious than other
Mycoplasma spp., and blood agar contains nucleic acid precursors
and cholesterol. Inoculating mediastinitis samples onto Mycoplas-
ma speciﬁc medium is probably not necessary because M. hominis
rarely causes mediastinitis, and generic medium like blood agar
supports its growth if the incubation is prolonged. When blood
agar medium is incubated in 5% CO2 or under anaerobic conditions,
tiny colonies of M. hominis (0.2 mm) can appear in 2 to 7 days.12
M. hominis can also grow on anaerobic medium or chocolate agar.
The median time needed for the growth of M. hominis from
mediastinitis samples is 6 days (Table 2). Therefore, in the case of
mediastinitis, a prolonged length of incubation of at least a week
could improve the diagnosis of M. hominis infection. However,
some cases of M. hominis infections and all the Ureaplasma spp.
would be still missed by such an approach.
Molecular methods represent an attractive option to diagnose
M. hominis infections. PCR techniques targeting M. hominis speciﬁc
genes can detect as few as 7 x 103 copies / mL.13 These techniques
can be more sensitive than culture in clinical urogenital samples,
with a 36% (55/153) positivity rate for the PCR assay against 29%minis.
osphere Time to positivity (days) Reference
6 Sielaff
5 Sielaff
6 Sielaff
6 Mattila
5 Mattila
6 Mattila
21 Mattila
10 Mattila
9 Mattila
16 Hopkins
7 Hopkins
6 Hopkins
7 Hopkins
aerobic 5 Garcia
d 16 Myers
d 3 Karaca
4 Le Guern
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range PCR by 16S rDNA sequencing can detect a large number of
bacterial species (depending on the primer sequence) with no prior
hypothesis. 16S rDNA sequencing is less sensitive than speciﬁc
M. hominis PCR, principally due to the low level of contaminating
bacterial DNA in PCR reagents.14 However, the sensitivity of 16S
rDNA sequencing in clinical samples is still high enough: 97%
(36/37) of spontaneous brain abscesses were positive using 16S
rDNA sequencing with the Sanger method. 16S rDNA sequencing
has already been used with success for the diagnosis of M. hominis
infections.15We suggest to amplify and sequence 16S rDNA in case
of culture negative samples for patients presenting clinical
symptoms of mediastinitis in order to be able to detect a broad-
range of pathogenic bacteria, including M. hominis.
Cefazolin or cefuroxime are typically used for antimicrobial
prophylaxis in cardiac surgery.16 These molecules are not active
against M. hominis, because the lack of a cell wall renders
Mycoplasma non-susceptible to the action of beta-lactam anti-
biotics. In this case report, the patient was treated with
levoﬂoxacin for 6 months. Minimal inhibitory concentrations of
other quinolones can be lower: moxiﬂoxacin CMI90 is 0.06 mg/L,
compared to 0.25 mg/L for levoﬂoxacin.17 However, moxiﬂoxacin
signiﬁcantly increases the risk of ventricular arrhythmia, contrary
to levoﬂoxacin.18 It also would have been possible to associate
doxycycline or clindamycin, due to the high risk of selecting
resisting mutants during a prolonged quinolone monotherapy.
Although M. hominis mediastinitis is a rare disease, it should be
evoked in culture-negative purulent discharges after cardiac
surgery. M. hominis should be suspected especially if the per
operatory samples show numerous leukocytes with no visible
bacteria. Incubating the culture media for an extended period of
time or ampliﬁcation of 16S rDNA directly from the clinical
samples followed by sequencing may help to obtain a deﬁnitive
diagnosis and adapt the antimicrobial chemotherapy.
Conﬂict of interests: The authors declare that they have no
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